Will advocates of embryonic stem-cell research admit their errors?
November 25, 2011
For several years, scientists and scientific publications have touted embryonic stem-cell test as the most promising field in medical research. Now, with the announcement that the Geron Corporation is abandoning the field, there is a virtual admission that other fields—such as the use of adult sources for stem cells—appear more productive. Michael Cook wonders rhetorically whether the advocates who push so vigorously for funding of embryo research will admit their mistakes.
Will Nature, Science or the New England Journal of Medicine issue mea culpas for having demanded new ethical standards for dealing with human embryos? Perhaps they are hoping that no one will notice how misplaced their hopes were.
For all current news, visit our News home page.
Further information:
- Non, je ne regrette rien (MercatorNet)
- Pioneer firm abandons embryonic stem-cell research (CWN, 11/15)
All comments are moderated. To lighten our editing burden, only current donors are allowed to Sound Off. If you are a current donor, log in to see the comment form; otherwise please support our work, and Sound Off!
-
Posted by: hartwood01 -
Nov. 26, 2011 4:18 PM ET USA
Several weeks ago I heard someone interviewed on NPR lament the fact that money is the deciding factor in research. He maintained that this "valuable" research will now suffer due to lack of funding. There will be no apologies,just crocodile tears for the shortsightedness of those who refuse to throw more good money after bad.
